FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 217 filers reported holding FATE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 319 | -96.6% | 0.00% | – |
| Q2 2023 | $44 | -24.1% | 9,441 | -8.7% | 0.00% | – |
| Q1 2023 | $58 | +286.7% | 10,336 | +587.2% | 0.00% | – |
| Q4 2022 | $15 | -100.0% | 1,504 | +10.2% | 0.00% | – |
| Q3 2022 | $30,000 | +650.0% | 1,365 | +689.0% | 0.00% | – |
| Q2 2022 | $4,000 | -99.0% | 173 | -98.3% | 0.00% | – |
| Q1 2022 | $403,000 | +1579.2% | 10,417 | +2345.3% | 0.00% | – |
| Q4 2021 | $24,000 | -96.9% | 426 | -97.8% | 0.00% | -100.0% |
| Q3 2020 | $770,000 | +2466.7% | 19,284 | +1121.3% | 0.00% | – |
| Q4 2019 | $30,000 | -81.4% | 1,579 | -84.8% | 0.00% | – |
| Q3 2019 | $161,000 | -25.8% | 10,388 | -3.2% | 0.00% | -100.0% |
| Q2 2019 | $217,000 | -32.8% | 10,730 | -41.7% | 0.00% | 0.0% |
| Q1 2019 | $323,000 | +201.9% | 18,413 | +119.4% | 0.00% | – |
| Q4 2018 | $107,000 | +10600.0% | 8,394 | +7263.2% | 0.00% | – |
| Q3 2018 | $1,000 | -99.3% | 114 | -99.1% | 0.00% | -100.0% |
| Q2 2018 | $149,000 | -48.1% | 13,165 | -55.3% | 0.00% | -92.3% |
| Q1 2018 | $287,000 | +1095.8% | 29,462 | +637.7% | 0.01% | +1200.0% |
| Q4 2017 | $24,000 | – | 3,994 | +3740.4% | 0.00% | – |
| Q3 2017 | $0 | – | 104 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |